The TRiC/CCT chaperonin complex is emerging as a promising therapeutic target across multiple neurodegenerative diseases characterized by protein misfolding and aggregation (Ghozlan et al., 2022). This evidence concerns the gene MARVELD2 and neurodegenerative disease.